Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: GlobalData
Provider: New Constructs, LLC
Provider: Directors Deals Ltd.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Valeant Pharmaceuticals International Inc's VPII Escrow Corp Announces Pricing Of Private Offering Of Senior Notes

Thursday, 27 Jun 2013 05:00pm EDT 

Valeant Pharmaceuticals International Inc announced that VPII Escrow Corp., a newly formed wholly owned Canadian subsidiary of the Company, has priced $1.6 billion aggregate principal amount of 6.75% senior unsecured notes due 2018 (the 2018 Notes) and $1.625 billion aggregate principal amount of 7.50% senior unsecured notes due 2021 (together with the 2018 Notes, the Notes). The 2018 Notes supplant the previously announced offering of senior unsecured notes due 2023. The Notes offering is expected to close on or about July 12, 2013. The Company intends to use the net proceeds from the offering, together with proceeds from its recent public offering of common shares and other debt financing, to fund the consideration of its previously disclosed acquisition (the Merger) of Bausch + Lomb Holdings Incorporated (B+L), the fees and expenses incurred in connection with the Merger; and the repayment or retirement of B+L's outstanding debt. 

Company Quote

3.06 +2.14%
19 Dec 2014